61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Allogene Therapeutics Inc
Closed
Sector Healthcare
2.2 4.27
Overview
Share price change
24h
Min
2.16
Max
2.2
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +342.99 upside |
News Sentiment
By Acuity
11%
89%
13 / 392 Healthcare
Technical Score
By Trading Central
Confidence
Very Strong Bearish Evidence
Allogene Therapeutics Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Allogene Therapeutics Inc Forecast
Price Target
By TipRanks
342.99% upside
12 Months Forecast
Average 9.79 USD 342.99%
High 14 USD
Low 4.5 USD
Based on 10 Wall Street analysts offering 12 month price targets forAllogene Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
13 / 392 Healthcare
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
$
